----

----

| Utah                                                           | 87-0447580                        |
|----------------------------------------------------------------|-----------------------------------|
| (State or other jurisdiction of incorporation or organization) | (IRS Employer Identification No.) |

|  o Large accelerated filer | o Accelerated filer | o Non-accelerated filer | x    Smaller reporting company |
|---------------------------------|---------------------|-------------------------|-----------------------------------------------|

| Class                      | Outstanding as of May 3, 2011 |
|----------------------------|-------------------------------|
| Common Stock, no par value | 46,971,797 shares             |

----

| Item 1: Financial Statements                                                                                                                      |   |
|---------------------------------------------------------------------------------------------------------------------------------------------------|--------|
|                                                                                                                                              |   |
| Condensed Balance Sheets                                                                                                                          |   |
| As of March 31, 2011 (unaudited) and June 30, 2010 (audited)                                                                                      | 1      |
|                                                                                                                                              |   |
| Unaudited Condensed Statements of Operations                                                                                                      |   |
| For the three and nine months ended March 31, 2011 and 2010 and for the Period from September 26, 1986 (Date of Inception) through March 31, 2011 | 2      |
|                                                                                                                                              |   |
| Unaudited Condensed Statements of Cash Flows                                                                                                      |   |
| For the nine months ended March 31, 2011 and 2010 and for the Period from September 26, 1986 (Date of Inception) through March 31, 2011           | 3      |
|                                                                                                                                              |   |
| Notes to Unaudited Condensed Financial Statements                                                                                                 | 4      |
|                                                                                                                                              |   |
| Item 2:  Management’s Discussion and Analysis of Financial Condition and Results of Operations                                    | 7      |
|                                                                                                                                              |   |
| Item 4:  Controls and Procedures                                                                                                        | 9      |
| PART II – OTHER INFORMATION                                                                                                                 |
| Item 1:  Legal Proceedings                                                                                                              | 9      |
|                                                                                                                                              |   |
| Item 2:  Unregistered Sales of Securities and Use of Proceeds                                                                           | 9      |
|                                                                                                                                              |   |
| Item 3:  Defaults Upon Senior Securities                                                                                                | 9      |
|                                                                                                                                              |   |
| Item 4:  Reserved                                                                                                                       | 9      |
|                                                                                                                                              |   |
| Item 5:  Other Information                                                                                                              | 9      |
|                                                                                                                                              |   |
| Item 6:  Exhibits                                                                                                                       | 10     |
|                                                                                                                                              |   |
| Signatures                                                                                                                                        | 10     |

----

|                                                                                                |                                                                     |   | March 31,   |        |   | June 30,  |      |
|-----------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------|--------|-------------|-------------|--------|-----------|-----------|
|                                                                                                |                                                                     |   | 2011        |        |   | 2010      |      |
|                                                                                                |                                                                     |   | (unaudited) |        |   | (audited) |      |
| ASSETS                                                                                              |                                                                     |
| CURRENT ASSETS                                                                                      |                                                                     |   |        |        |   |      |
|                                                                                                | Cash and cash equivalents                                                |   | $           | 3,737       |   |      | $         | 6,865 |   |
|                                                                                                | Prepaid expenses                                                         |   |        | 2,000       |   |      |      | 2,000 |   |
|                                                                                                |                                                                     |   |        |        |   |      |      |   |   |
|                                                                                                | Total Current Assets                                                     |   |        | 5,737       |   |      |      | 8,865 |   |
|                                                                                                |                                                                     |   |        |        |   |      |      |   |   |
| Alternate solar energy systems                                                                      |                                                                     |   | 618,910     |        |   |      | 537,825   |   |
| Property and Equipment, net of accumulated depreciation of $436,650and $372,457,  respectively |                                                                     |   | 338,364     |        |   |      | 402,057   |   |
| Patents, net of accumulated amortization of $30,710 and $26,474, respectively                       |                                                                     |   | 65,316      |        |   |      | 69,553    |   |
|                                                                                                |                                                                     |   |        |        |   |      |      |   |   |
|                                                                                                | TOTAL ASSETS                                                             |   | $           | 1,028,327   |   |      | $         | 1,018,300 |   |
|                                                                                                |                                                                     |   |        |        |   |      |      |   |   |
| LIABILITIES AND STOCKHOLDERS' DEFICIT                                                               |                                                                     |
|                                                                                                |                                                                     |   |        |        |   |      |      |   |   |
| CURRENT LIABILITIES                                                                                 |                                                                     |   |        |        |   |      |      |   |
|                                                                                                | Accounts payable                                                         |   | $           | 324,284     |   |      | $         | 94,525 |   |
|                                                                                                | Accrued liabilities                                                      |   |        | 396,268     |   |      |      | 350,622 |   |
|                                                                                                | Related party payable                                                    |   |        | 39,241      |   |      |      | 507,532 |   |
|                                                                                                | Customer deposits                                                        |   |        | 2,360,250   |   |      |      | 2,360,250 |   |
|                                                                                                | Notes payable-current portion                                            |   |        | 16,185      |   |      |      | 30,881 |   |
|                                                                                                |                                                                     |   |        |        |   |      |      |   |   |
|                                                                                                | Total Current Liabilities                                                |   |        | 3,136,228   |   |      |      | 3,343,810 |   |
|                                                                                                |                                                                     |   |        |        |   |      |      |   |   |
| Long-term notes payable                                                                             |                                                                     |   |        | 70,231      |   |      |      | 83,834 |   |
|                                                                                                |                                                                     |   |        |        |   |      |      |   |   |
| TOTAL LIABILITIES                                                                                   |                                                                     |   | 3,206,459   |        |   |      | 3,427,644 |   |
|                                                                                                |                                                                     |   |        |        |   |      |      |   |   |
| Commitments and contingencies                                                                       |                                                                     |   |        |        |   |      |      |   |
|                                                                                                |                                                                     |   |        |        |   |      |      |   |   |
| STOCKHOLDERS' EQUITY (DEFICIT)                                                                      |                                                                     |   |        |        |   |      |      |   |
|                                                                                                | Preferred stock, Class A, no par value; 22,000,000 shares authorized,    |   |        |        |   |      |      |   |   |
|                                                                                                | 5,400,000 and 4,400,000 shares issued and outstanding, respectively      |   |        | 470,264     |   |      |      | 417,264 |   |
|                                                                                                | Preferred stock, Class B, no par value, 3,000,000 shares                 |   |        |        |   |      |      |   |   |
|                                                                                                | authorized, 300,000 shares issued and outstanding                        |   |        | -           |   |      |      | - |   |
|                                                                                                | Common stock, no par value, 225,000,000 shares                           |   |        |        |   |      |      |   |   |
|                                                                                                | authorized,  42,239,072 and 37,037,153 issued and outstanding, |   |        |        |   |      |      |   |   |
|                                                                                                | net of 3,922,725 and 3,538,118 shares held in escrow                     |   |        |        |   |      |      |   |   |
|                                                                                                | account, respectively                                                    |   |        | 37,016,012  |   |      |      | 36,032,789 |   |
|                                                                                                | Deficit accumulated during the development stage                         |   |        | (39,664,408 | )      |      |      | (38,859,397 | ) |
|                                                                                                | Total Stockholders' Deficit                                              |   |        | (2,178,132  | )      |      |      | (2,409,344 | ) |
|                                                                                                |                                                                     |   |        |        |   |      |      |   |   |
|                                                                                                | TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT                              |   | $           | 1,028,327   |   |      | $         | 1,018,300 |   |

----

|                                       |   |                       |       |   |                      |   |       |           |   |   |           |   |   | For the Period |       |
|--------------------------------------------|--------|----------------------------|------------|--------|---------------------------|--------|------------|----------------|--------|--------|----------------|--------|--------|----------------|------------|
|                                       |   |                       |       |   |                      |   |       |           |   |   | From Inception |   |
|                                       |   | For the Three Months Ended |       |   | For the Nine Months Ended |   |       | (September 26, |   |
|                                       |   | March 31,                  |       |   | March 31,                 |   |       | 1986) Through  |   |
|                                       |   | 2011                       |       |   | 2010                      |   |       | 2011           |   |   | 2010           |   |   | March 31, 2011 |       |
| Revenues                                   |   |                       |       |   |                      |   |       |           |   |   |           |   |   |           |       |
| Sales                                      |   | $                          | -          |   |                      | $      | -          |           |   | $      | -              |   |   | $              | -          |   |   | $ | 111,226 |   |
| Income from related party                  |   |                       | -          |   |                      |   | -          |           |   |   | -              |   |   |           | -          |   |   |   | 32,348 |   |
| Total revenues                             |   |                       | -          |   |                      |   | -          |           |   |   | -              |   |   |           | -          |   |   |   | 143,574 |   |
|                                       |   |                       |       |   |                      |   |       |           |   |   |           |   |   |           |       |   |   |   |   |   |
| Costs of sales                             |   |                       |       |   |                      |   |       |           |   |   |           |   |   |           |       |   |   |   |   |   |
| Cost of sales                              |   |                       | -          |   |                      |   | -          |           |   |   | -              |   |   |           | -          |   |   |   | 81,927 |   |
| Write down of carrying value               |   |                       |       |   |                      |   |       |           |   |   |           |   |   |           |       |   |   |   |   |   |
| of inventory                               |   |                       | -          |   |                      |   | -          |           |   |   | -              |   |   |           | -          |   |   |   | 233,131 |   |
| Total costs of sales                       |   |                       | -          |   |                      |   | -          |           |   |   | -              |   |   |           | -          |   |   |   | 315,058 |   |
|                                       |   |                       |       |   |                      |   |       |           |   |   |           |   |   |           |       |   |   |   |   |   |
| Gross loss                                 |   |                       | -          |   |                      |   | -          |           |   |   | -              |   |   |           | -          |   |   |   | (171,484 | ) |
|                                       |   |                       |       |   |                      |   |       |           |   |   |           |   |   |           |       |   |   |   |   |   |
| Operating expenses                         |   |                       |       |   |                      |   |       |           |   |   |           |   |   |           |       |   |   |   |   |   |
| General and administrative                 |   |                       | 148,730    |   |                      |   | 284,128    |           |   |   | 543,398        |   |   |           | 2,825,025  |   |   |   | 31,811,200 |   |
| Research and development                   |   |                       | 84,278     |   |                      |   | 118,297    |           |   |   | 256,525        |   |   |           | 334,668    |   |   |   | 8,372,914 |   |
| Impairment of patents                      |   |                       | -          |   |                      |   | -          |           |   |   | -              |   |   |           | -          |   |   |   | 140,577 |   |
| License fees                               |   |                       | -          |   |                      |   | -          |           |   |   | -              |   |   |           | -          |   |   |   | 270,634 |   |
| Total operating expenses                   |   |                       | 233,008    |   |                      |   | 402,425    |           |   |   | 799,923        |   |   |           | 3,159,693  |   |   |   | 40,595,325 |   |
|                                       |   |                       |       |   |                      |   |       |           |   |   |           |   |   |           |       |   |   |   |   |   |
| Loss from operations                       |   |                       | (233,008   | )      |                      |   | (402,425   | )              |   |   | (799,923       | )      |   |           | (3,159,693 | ) |   |   | (40,766,809 | ) |
|                                       |   |                       |       |   |                      |   |       |           |   |   |           |   |   |           |       |   |   |   |   |   |
| Other income (expenses)                    |   |                       |       |   |                      |   |       |           |   |   |           |   |   |           |       |   |   |   |   |   |
| Loss on impairment of assets               |   |                       | -          |   |                      |   | -          |           |   |   | -              |   |   |           | -          |   |   |   | (583 | ) |
| Forfeiture of deposits                     |   |                       | -          |   |                      |   | -          |           |   |   | -              |   |   |           | -          |   |   |   | (236,803 | ) |
| Interest income                            |   |                       | -          |   |                      |   | 32         |           |   |   | -              |   |   |           | 91         |   |   |   | 26,580 |   |
| Interest expense                           |   |                       | (1,468     | )      |                      |   | (2,084     | )              |   |   | (4,798         | )      |   |           | (6,692     | ) |   |   | (36,276 | ) |
| Other income (expenses)                    |   |                       | 708        |   |                      |   | (293       | )              |   |   | (290           | )      |   |           | 397        |   |   |   | (32,540 | ) |
| Total other income (expenses)              |   |                       | (760       | )      |                      |   | (2,345     | )              |   |   | (5,088         | )      |   |           | (6,204     | ) |   |   | (279,622 | ) |
|                                       |   |                       |       |   |                      |   |       |           |   |   |           |   |   |           |       |   |   |   |   |   |
| Loss before extraordinary gain             |   |                       | (233,768   | )      |                      |   | (404,770   | )              |   |   | (805,011       | )      |   |           | (3,165,897 | ) |   |   | (41,046,431 | ) |
|                                       |   |                       |       |   |                      |   |       |           |   |   |           |   |   |           |       |   |   |   |   |   |
| Extraordinary gain on sale of patents      |   |                       | -          |   |                      |   | -          |           |   |   | -              |   |   |           | -          |   |   |   | 1,382,023 |   |
|                                       |   |                       |       |   |                      |   |       |           |   |   |           |   |   |           |       |   |   |   |   |   |
| Net loss                                   |   | $                          | (233,768   | )      |                      | $      | (404,770   | )              |   | $      | (805,011       | )      |   | $              | (3,165,897 | ) |   | $ | (39,664,408 | ) |
|                                       |   |                       |       |   |                      |   |       |           |   |   |           |   |   |           |       |   |   |   |   |   |
| Net loss per common share                  |   |                       |       |   |                      |   |       |           |   |   |           |   |   |           |       |   |   |   |   |   |
| Basic and diluted                          |   | $                          | (0.01      | )      |                      | $      | (0.01      | )              |   | $      | (0.02          | )      |   | $              | (0.09      | ) |   |   |   |   |
|                                       |   |                       |       |   |                      |   |       |           |   |   |           |   |   |           |       |   |   |   |   |   |
| Weighted average common shares outstanding |   |                       |       |   |                      |   |       |           |   |   |           |   |   |           |       |   |   |
| Basic and diluted                          |   |                       | 41,193,685 |   |                      |   | 36,123,465 |           |   |   | 38,973,547     |   |   |           | 35,157,660 |   |   |   |   |   |

----

|                                                    |   |                         |     |   |           |   |       | For the Period |   |
|---------------------------------------------------------|--------|------------------------------|----------|--------|----------------|--------|------------|----------------|--------|
|                                                    |   |                         |     |   | From Inception |   |
|                                                    |   | For the Nine Months Ended    |     |   | (September 26, |   |
|                                                    |   | March 31,                    |     |   | 1986) Through  |   |
|                                                    |   |     2011 |     |   | 2010           |   |       | March 31, 2011 |   |
| Cash flows from operating activities                    |   |                         |     |   |           |   |       |           |   |
| Net loss                                                |   | $                            | (805,011 | )      |           | $      | (3,165,897 | )              |   | $ | (39,664,408 | ) |
| Adjustments to reconcile net loss to net                |   |                         |     |   |           |   |       |           |   |   |   |   |
| cash from operating activities:                         |   |                         |     |   |           |   |       |           |   |   |   |   |
| Depreciation and amortization                           |   |                         | 68,430   |   |           |   | 69,933     |           |   |   | 745,585 |   |
| Stock-based compensation                                |   |                         | 57,500   |   |           |   | 2,286,923  |           |   |   | 22,428,641 |   |
| Forfeiture of deposits                                  |   |                         | -        |   |           |   | -          |           |   |   | 236,803 |   |
| Write down of carrying value of inventory               |   |                         | -        |   |           |   | -          |           |   |   | 16,945 |   |
| Write off of equipment to research and development      |   |                         | -        |   |           |   | -          |           |   |   | 23,900 |   |
| (Gain) / loss on disposal of equipment                  |   |                         | -        |   |           |   | -          |           |   |   | 18,679 |   |
| Impairment of patents and abandonment of in-process     |   |                         |     |   |           |   |       |           |   |   |   |   |
| rights to technology                                    |   |                         | -        |   |           |   | -          |           |   |   | 387,128 |   |
| Extraordinary gain on sale of patents                   |   |                         | -        |   |           |   | -          |           |   |   | (1,382,023 | ) |
| Gain on settlement of debt                              |   |                         | -        |   |           |   | -          |           |   |   | (6,123 | ) |
| Operating expenses paid by principal stockholder        |   |                         | 54,000   |   |           |   | -          |           |   |   | 54,000 |   |
| Stock issued for services                               |   |                         | -        |   |           |   | 9,833      |           |   |   | 120,247 |   |
| Changes in current assets and liabilities:              |   |                         |     |   |           |   |       |           |   |   |   |   |
| (Increase) / decrease in prepaid expenses               |   |                         | -        |   |           |   | -          |           |   |   | 7,833 |   |
| (Increase) / decrease in alternate solar energy systems |   |                         | (81,085  | )      |           |   | (128,362   | )              |   |   | (618,910 | ) |
| Increase / (decrease) in customer deposits              |   |                         | -        |   |           |   | 603,000    |           |   |   | 2,360,250 |   |
| Increase / (decrease) in accounts payable               |   |                         | 229,759  |   |           |   | (346,655   | )              |   |   | 324,284 |   |
| Increase / (decrease) in related party payable          |   |                         | (5,500   | )      |           |   | (8,001     | )              |   |   | 68,001 |   |
| Increase / (decrease) in accrued liabilities            |   |                         | 45,646   |   |           |   | 117,659    |           |   |   | 496,267 |   |
| Net cash used in operating activities                   |   |                         | (436,261 | )      |           |   | (561,567   | )              |   |   | (14,382,901 | ) |
| Cash flows used in investing activities                 |   |                         |     |   |           |   |       |           |   |   |   |   |
| Purchase of property and equipment                      |   |                         | (500     | )      |           |   | (16,851    | )              |   |   | (772,635 | ) |
| Purchase of rights to technology                        |   |                         | -        |   |           |   | -          |           |   |   | (706,643 | ) |
| Organization costs                                      |   |                         | -        |   |           |   | -          |           |   |   | (1,880 | ) |
| Net cash advanced to related party                      |   |                         | -        |   |           |   | -          |           |   |   | (1,644,988 | ) |
| Commitments and contingencies - Note 6                  |   |                         | -        |   |           |   | -          |           |   |   | 44,220 |   |
| Proceeds from sale of equipment                         |   |                         | -        |   |           |   | -          |           |   |   | 2,500 |   |
| Repayment of cash loaned to related party               |   |                         | -        |   |           |   | -          |           |   |   | 53,254 |   |
| Net proceeds from sale of patents                       |   |                         | -        |   |           |   | -          |           |   |   | 1,382,023 |   |
| Net cash used in investing activities                   |   |                         | (500     | )      |           |   | (16,851    | )              |   |   | (1,644,149 | ) |
| Cash flows provided by financing activities             |   |                         |     |   |           |   |       |           |   |   |   |   |
| Proceeds from issuance of common stock                  |   |                         | 524,723  |   |           |   | 303,552    |           |   |   | 6,702,184 |   |
| Proceeds from reissuance of treasury stock              |   |                         | -        |   |           |   | -          |           |   |   | 751,573 |   |
| Contributed capital                                     |   |                         | -        |   |           |   | -          |           |   |   | 6,270,559 |   |
| Payments for treasury stock                             |   |                         | -        |   |           |   | -          |           |   |   | (3,325 | ) |
| Payments for stock offering costs                       |   |                         | -        |   |           |   | -          |           |   |   | (56,509 | ) |
| Proceeds from cash advances from related party          |   |                         | 176,877  |   |           |   | 373,082    |           |   |   | 3,074,080 |   |
| Payments on cash advances from related party            |   |                         | (239,668 | )      |           |   | (71,228    | )              |   |   | (617,381 | ) |
| Proceeds from notes payable                             |   |                         | -        |   |           |   | -          |           |   |   | 29,857 |   |
| Payments on notes payable and capital lease obligations |   |                         | (28,299  | )      |           |   | (26,510    | )              |   |   | (275,910 | ) |
| Proceeds from related party deposits                    |   |                         | -        |   |           |   | -          |           |   |   | 224,400 |   |
| Purchases of equipment held for distribution            |   |                         | -        |   |           |   | -          |           |   |   | (68,741 | ) |
| Net cash provided by financing activities               |   |                         | 433,633  |   |           |   | 578,896    |           |   |   | 16,030,787 |   |
| Net change in cash                                      |   |                         | (3,128   | )      |           |   | 478        |           |   |   | 3,737 |   |
| Cash at beginning of period                             |   |                         | 6,865    |   |           |   | 47,537     |           |   |   | - |   |
| Cash at end of period                                   |   | $                            | 3,737    |   |           | $      | 48,015     |           |   | $ | 3,737 |   |
|                                                    |   |                         |     |   |           |   |       |           |   |   |   |   |
| Supplemental non-cash flow information                  |   |                         |     |   |           |   |       |           |   |   |   |   |
| Settlement of advances from related party in exchange   |   |                         |     |   |           |   |       |           |   |   |   |   |
| for exercise of warrants                                |   | $                            | 400,000  |   |           | $      | 400,000    |           |   |   |   |   |

----

----

----

----

----

----

----

|   | 31.1 | Certification by the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
|--------|------|--------------------------------------------------------------------------------------------------------|

|   | 31.2 | Certification by the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
|--------|------|--------------------------------------------------------------------------------------------------------|

|   | 32.1 | Certification by the Chief Executive Officer Pursuant to 18 U.S.C. Section 1350 Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
|--------|------|---------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 32.2 | Certification by the Chief Financial Officer Pursuant to 18 U.S.C. Section 1350 Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
|--------|------|---------------------------------------------------------------------------------------------------------------------------------------------------|

| Date:  May 13, 2011 | By     |   /s/ Neldon Johnson               |
|------------------------------------|--------|----------------------------------------------|
|                               |   | Neldon Johnson                               |
|                               |   | President, Chief Executive Officer, Director |
|                               |   |                                         |
|                               |   |                                         |
| Date: May 13, 2011            | By     |   /s/ LaGrand Johnson              |
|                               |   | LaGrand Johnson                              |
|                               |   | Chief Financial Officer                      |

----